 | Up a level |
Hideo-Kajita, Alexandre; Garcia-Garcia, Hector M; Kolm, Paul; Azizi, Viana; Ozaki, Yuichi; Dan, Kazuhiro; Ince, Hüseyin; Kische, Stephan; Abizaid, Alexandre; Töelg, Ralph; Lemos, Pedro Alves; Van Mieghem, Nicolas M; Verheye, Stefan; von Birgelen, Clemens; Christiansen, Evald Høj; Wijns, William; Lefèvre, Thierry; Windecker, Stephan; Waksman, Ron and Haude, Michael (2020). Comparison of clinical outcomes between Magmaris and Orsiro drug eluting stent at 12 months: Pooled patient level analysis from BIOSOLVE II-III and BIOFLOW II trials. International journal of cardiology, 300, pp. 60-65. Elsevier 10.1016/j.ijcard.2019.11.003
Iqbal, Javaid; Verheye, Stefan; Abizaid, Alexandre; Ormiston, John; de Vries, Ton; Morrison, Lynn; Toyloy, Sara; Fitzgerald, Peter; Windecker, Stephan; Serruys, Patrick W (2015). DESyne novolimus-eluting coronary stent is superior to Endeavor zotarolimus-eluting coronary stent at five-year follow-up: final results of the multicentre EXCELLA II randomised controlled trial. EuroIntervention, 11(6), e1336-e1342. Europa Digital & Publishing 10.4244/EIJY15M10_04
Serruys, Patrick W; Garg, Scot; Abizaid, Alexandre; Ormiston, John; Windecker, Stephan; Verheye, Stefan; Dubois, Christophe; Stewart, Jim; Hauptmann, Karl E; Schofer, Joachim; Stangl, Karl; Witzenbichler, Bernhard; Wiemer, Marcus; Barbato, Emanuele; de Vries, Ton; den Drijver, Anne-Marie; Otake, Hiromasa; Meredith, Lynn; Toyloy, Sara and Fitzgerald, Peter (2010). A randomised comparison of novolimus-eluting and zotarolimus-eluting coronary stents: 9-month follow-up results of the EXCELLA II study. EuroIntervention, 6(2), pp. 195-205. Toulouse: Europa Digital & Publishing
